Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 2
2004 5
2005 2
2008 2
2009 2
2010 1
2011 2
2012 4
2013 1
2014 3
2015 3
2016 1
2017 1
2018 2
2019 3
2020 3
2021 1
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Safety and immunogenicity of BK-SE36/CpG malaria vaccine in healthy Burkinabe adults and children: a phase 1b randomised, controlled, double-blinded, age de-escalation trial.
Ouédraogo A, Bougouma EC, Palacpac NMQ, Houard S, Nebie I, Sawadogo J, Berges GD, Soulama I, Diarra A, Hien D, Ouedraogo AZ, Konaté AT, Kouanda S, Myoui A, Ezoe S, Ishii KJ, Sato T, D'Alessio F, Leroy O, Tiono AB, Cousens S, Horii T, Sirima SB. Ouédraogo A, et al. Among authors: ezoe s. Front Immunol. 2023 Oct 16;14:1267372. doi: 10.3389/fimmu.2023.1267372. eCollection 2023. Front Immunol. 2023. PMID: 37908361 Free PMC article. Clinical Trial.
Ectonucleotidase CD39 is highly expressed on ATLL cells and is responsible for their immunosuppressive function.
Nagate Y, Ezoe S, Fujita J, Okuzaki D, Motooka D, Ishibashi T, Ichii M, Tanimura A, Kurashige M, Morii E, Fukushima T, Suehiro Y, Yokota T, Shibayama H, Oritani K, Kanakura Y. Nagate Y, et al. Among authors: ezoe s. Leukemia. 2021 Jan;35(1):107-118. doi: 10.1038/s41375-020-0788-y. Epub 2020 Mar 20. Leukemia. 2021. PMID: 32203145 Free PMC article.
Pharmacokinetics, Safety, and Tolerability of NPC-21, an Anti-Cytomegalovirus Monoclonal Antibody, in Healthy Japanese and White Adult Men: A Randomized, Placebo-Controlled, First-in-Human Phase 1 Study.
Furihata K, Hamada I, Niwa T, Watanabe T, Ezoe S. Furihata K, et al. Among authors: ezoe s. Clin Pharmacol Drug Dev. 2022 Jun;11(6):707-716. doi: 10.1002/cpdd.1065. Epub 2022 Jan 5. Clin Pharmacol Drug Dev. 2022. PMID: 34989174 Free PMC article. Clinical Trial.
41 results